Ortoma AB Series B

ORT-B · Nasdaq Stockholm · Healthcare

7.15SEK −2.5%last day

Price as of 2 October 2026

The price over the past year, with dividends: −63.2%

Performance

1 month

−4.2%

1 year

−63.2%

3 years, per year

−21.0%

5 years, per year

−23.7%

Largest fall, 3 years

−86.1%

Below the peak now

−91.0%

Volatility, 1 year

72.9%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

1.9

Dividend yield

0.0%

Return on equity

−37.9%

Net margin

−197.7%

Market value

33 m USD

Quality, value and trend

Where Ortoma stands against every Nordic stock today. 100 is best.

Quality47

Profitability and a sound balance sheet over time. Better than 47% of Nordic stocks.

Value14

The price measured against earnings, assets and cash flow. Better than 14% of Nordic stocks.

Trend9

The price development over the past year. Better than 9% of Nordic stocks.

Combined7

Quality, value and trend together. Better than 7% of Nordic stocks.

About Ortoma

Ortoma AB Series B is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 18 employees.

Ortoma AB (publ), a medical technology company, focuses on Al-based technology for orthopedic surgical procedures in Sweden. It offers Ortoma Treatment Solution (OTS), a server-based AI integrated orthopedic platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and post-operative follow-up; and OTS Guide, an intra-operative navigation tool guiding surgeons to place the implant in the pre-operatively planned position. The company was founded in 2001 and is based in Gothenburg, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis